Skip to main content

Advertisement

Advertisement

World

Waiving patents alone won't solve COVID-19 vaccine access: Developers

Waiving patents alone won't solve COVID-19 vaccine access: Developers

A woman holds a small bottle labelled with a "Coronavirus COVID-19 Vaccine" sticker in this illustration taken, Oct 30, 2020. (Photo: REUTERS/Dado Ruvic)

GENEVA: Waiving intellectual property rights will not be enough to resolve COVID-19 vaccine access issues, the developers of the Oxford-Astrazeneca and the Pfizer-BioNTech vaccines said on Monday, ahead of a meeting on the topic at the World Trade Organization this week.

"I don't think just making IP fully available goes anywhere close to solving the problem...," said the University of Oxford professor Sarah Gilbert at a World Health Organization virtual press conference.

BioNTech's Chief Medical Officer Dr Ozlem Tureci said at the same briefing: "Patents are one thing, but there are so many other things we have to ensure."

BOOKMARK THIS: Our comprehensive coverage of the coronavirus outbreak and its developments

Download our app or subscribe to our Telegram channel for the latest updates on the coronavirus outbreak: https://cna.asia/telegram

Source: Reuters

Advertisement

Also worth reading

Advertisement